Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

AGM Trading Statement

3 Jun 2021 12:00

RNS Number : 7270A
Camellia PLC
03 June 2021
 

3 June 2021

AGM Trading Statement

Camellia Plc (the "Company")

Camellia Plc (CAM.L) has today issued the following update on trading in the year to date.

Trading

Agriculture We are pleased that, despite the pandemic, all of our agricultural operations continue to operate. However, the Covid situation in India remains deeply concerning despite the extensive efforts made locally to keep all our staff safe, including restricting workforce deployment to 50% in West Bengal. Very dry conditions across northern India and Bangladesh to date have also resulted in reduced production which in turn has led to improved prices over the same period last year. However, following the recent elections, wage increases in Assam (backdated to 23 February 2021) have been agreed at 22.75% which is substantially more than the industry was anticipating. Productivity improvements and other cost reduction measures are being explored but the benefit of these may not arise until next year. As a result, the combined impact is a reduction in operating profits in 2021 of approximately £1 million. In Bangladesh there is now some indication that demand may be adversely impacted due to continuing Covid restrictions and this is expected to result in some pricing pressure in the coming months. In Kenya, whilst not quite at 2020's record levels, benign weather is resulting in very high volumes of tea and consequent weakness in auction prices which remain marginally behind 2020. In Malawi, both tea volumes and prices are ahead of 2020 as previously reported.

The harvest for our Hass avocado crop has started, with early indications that volumes will be up on last year but that pricing may be under pressure in what is anticipated to be a well supplied summer market in Europe.

Our macadamia operations continue to harvest and process their production with volumes expected to be higher than last year although as previously indicated, in Malawi pest damage has been experienced and indications are that this is more extensive than previously expected. The kernel market is active with both demand and prices improving.

Our remaining agricultural businesses are trading well, with our farming operation in Brazil seeing very high soya yields being sold into a strong market.

Non-agriculture Our non-agriculture businesses in the UK have had a difficult start to the year with the continuing restrictions hitting retail and food service. We are optimistic that as the restrictions continue to ease, trading in these businesses will improve. Aerospace also remains very quiet and we now anticipate no improvement in performance for the remainder of the year. 

Outlook

Whilst there are signs that normality is returning in some regions, the speed and intensity at which the pandemic has re-emerged in India demonstrates the need for continued vigilance. We have a very strong financial position and believe that over the long-term demand for our agricultural produce will continue to rise. As always, our financial results remain largely dependent on Agriculture where the majority of harvesting, and hence sales, takes place in the second half of the year. It is therefore too early to give a firm indication of the likely results for 2021 however the factors discussed above suggest the results for the year will be approximately £2 million below market expectations.

The Board of Camellia is also very much aware of the recent share price performance, which it believes is largely driven by the weakness in tea prices globally. Whilst there is little we can do regarding the tea price, a programme is being undertaken to review all non-core investments and other options with a view to maximising value for the Group and reducing UK costs. Additional detail will be issued in due course and as appropriate.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

Camellia Plc

Tom Franks, CEO

Susan Walker, CFO

 

01622 746655

Panmure Gordon

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

020 7886 2500

Maitland/AMO

PR

William Clutterbuck

 

 

07785 292617

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFIFSTRAIVIIL
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.